EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mouse Exploratory Behaviour in the Open Field with and without NAT-1 EEG Device: Effects of MK801 and Scopolamine

Charmaine J M Lim iD, Jack Bray, Sanna K Janhunen, Bettina Platt, Gernot Riedel iD

Biomolecules · 2024

DOI: 10.3390/biom14081008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Charmaine J M Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK. Hauptthemen laut MEDLINE: Scopolamine, Dizocilpine Maleate, Exploratory Behavior, Electroencephalography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One aspect of reproducibility in preclinical research that is frequently overlooked is the physical condition in which physiological, pharmacological, or behavioural recordings are conducted. In this study, the physical conditions of mice were altered through the attachments of wireless electrophysiological recording devices (Neural Activity Tracker-1, NAT-1). NAT-1 devices are miniaturised multichannel devices with onboard memory for direct high-resolution recording of brain activity for >48 h. Such devices may limit the mobility of animals and affect their behavioural performance due to the added weight (total weight of approximately 3.4 g). The mice were additionally treated with saline (control), N-methyl-D-aspartate (NMDA) receptor antagonist MK801 (0.85 mg/kg), or the muscarinic acetylcholine receptor blocker scopolamine (0.65 mg/kg) to allow exploration of the effect of NAT-1 attachments in pharmacologically treated mice. We found only minimal differences in behavioural outcomes with NAT-1 attachments in standard parameters of locomotor activity widely reported for the open field test between the drug treatments. Hypoactivity was globally observed as a consistent outcome in the MK801-treated mice and hyperactivity in scopolamine groups regardless of NAT-1 attachments. These data collectively confirm the reproducibility for combined behavioural, pharmacological, and physiological endpoints even in the presence of lightweight wireless data loggers. The NAT-1 therefore constitutes a pertinent tool for investigating brain activity in, e.g., drug discovery and models of neuropsychiatric and/or neurodegenerative diseases with minimal effects on pharmacological and behavioural outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ScopolamineDizocilpine MaleateExploratory BehaviorElectroencephalographyAnimalsMiceMaleBehavior, AnimalOpen Field Test

Stichwörter der Autor:innen

MK801electroencephalographyopen field testreproducibilityscopolaminewireless

Substanzen

ScopolamineDizocilpine Maleate

Autor:innen und Institutionen

  • Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK.
  • Organon R&D Finland, Itäinen Pitkäkatu 4, 20520 Turku, Finland.

ORCID-Profile: Charmaine J M Lim, Gernot Riedel

Förderung

  • Innovative Medicines Initiative

Zitieren

APA

Lim, C. J. M., Bray, J., Janhunen, S. K., Platt, B., & Riedel, G. (2024). Mouse Exploratory Behaviour in the Open Field with and without NAT-1 EEG Device: Effects of MK801 and Scopolamine. Biomolecules. https://doi.org/10.3390/biom14081008

Vancouver

Lim CJM, Bray J, Janhunen SK, Platt B, Riedel G. Mouse Exploratory Behaviour in the Open Field with and without NAT-1 EEG Device: Effects of MK801 and Scopolamine. Biomolecules. 2024. doi:10.3390/biom14081008

BibTeX
@article{Lim2024,
  author = {Lim, Charmaine J M and Bray, Jack and Janhunen, Sanna K and Platt, Bettina and Riedel, Gernot},
  title = {Mouse Exploratory Behaviour in the Open Field with and without NAT-1 EEG Device: Effects of MK801 and Scopolamine},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14081008}
}
Kostenlos starten →